Home › Funds › BRAIDWELL LP › DNTH

BRAIDWELL LP position in DNTH

DIANTHUS THERAPEUTICS INC COM · Health Care

BRAIDWELL LP reported holding 594,562 shares of DNTH (DIANTHUS THERAPEUTICS INC COM) in its Q2 2026 13F filing — a position valued at US$58.0M, representing 2.28% of its reported portfolio and ranking #10 among its reported holdings. BRAIDWELL LP has disclosed DNTH holdings in 8 of the last 9 reported quarters, going back to Q2 2024.

Latest position (Q2 2026)594.56K sh
Reported value held$57.96M
Portfolio Weight2.28%
First reportedQ2 2024
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How BRAIDWELL LP's DNTH position evolved

BRAIDWELL LP first disclosed a stake in DNTH in Q2 2024 at 366,851 shares (US$9.5M). The position peaked in Q1 2026 at 899,364 shares, worth US$75.5M. Across 8 filings, BRAIDWELL LP increased the stake 3 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 594,562 shares valued at US$58.0M — a reduction of -304,802 shares quarter over quarter.. Notable position changes include a 144% increase in Q4 2024 (shares fell 17% over the following quarter), a 69% trim in Q1 2025 (shares rose 3% over the following quarter), a 53% increase in Q4 2025 (shares rose 104% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2024 366.85K $9.49M New
Q3 2024 493.69K $13.52M Add
Q4 2024 1.21M $26.30M Add
Q1 2025 375.36K $6.81M Reduce
Q3 2025 835.06K $32.86M New
Q4 2025 1.27M $52.50M Add
Q1 2026 899.36K $75.47M Reduce
Q2 2026 594.56K $57.96M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About DNTH and 13F data

DNTH (DIANTHUS THERAPEUTICS INC COM) is a Health Care company. 72 other funds we track also report a position in DNTH — the largest reported positions include Fairmount Funds Management LLC (US$247.3M), Avidity Partners Management LP (US$205.1M), Octagon Capital Advisors LP (US$179.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding DNTH

All DNTH fund holders →

FAQ

How long has BRAIDWELL LP held DNTH?

BRAIDWELL LP has disclosed DNTH holdings in 8 of the last 9 reported quarters, going back to Q2 2024.

What is BRAIDWELL LP's current position in DNTH?

As of Q2 2026, BRAIDWELL LP holds 594.56K shares of DNTH (DIANTHUS THERAPEUTICS INC COM), valued at $57.96M, representing 2.28% of its reported portfolio and ranking #10.

Has BRAIDWELL LP been buying or selling DNTH?

In the latest 13F filing (Q2 2026), BRAIDWELL LP reduced its position in DNTH. The position peaked in Q1 2026 at 899.36K shares.

Which other funds hold DNTH?

Other major institutional holders of DNTH include Fairmount Funds Management LLC, Avidity Partners Management LP, Octagon Capital Advisors LP, among 72 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.